← Back to guidelines
Musculoskeletal16 papers

Compressive optic atrophy

Last edited: 4/15/2026

Overview

Compressive optic atrophy refers to damage to the optic nerve due to compression, often secondary to structural abnormalities or space-occupying lesions, leading to vision loss and potentially irreversible visual impairment 1.

Diagnosis

  • Clinical presentation includes visual disturbances, optic disc swelling, and visual field defects.
  • Imaging studies such as MRI and CT scans are crucial for identifying compressive lesions 1.
  • Visual evoked potentials (VEP) can help confirm the diagnosis and assess the severity of optic nerve dysfunction 1.
  • Management

  • Surgical decompression: Recommended for compressive lesions causing significant optic nerve damage, aiming to relieve pressure on the optic nerve 1.
  • Radiation therapy: Considered in cases where surgical intervention is not feasible or as an adjunct to surgery 1.
  • Monitoring and supportive care: Regular ophthalmologic follow-ups to monitor progression and manage symptoms 1.
  • Special Populations

  • Elderly: Surgical risks may be higher; careful patient selection and multidisciplinary assessment are essential 1.
  • Comorbidities: Presence of other conditions may influence treatment choice and necessitate tailored management strategies 1.
  • Key Recommendations

  • Perform imaging studies (MRI, CT) to identify compressive lesions in patients suspected of compressive optic atrophy (Evidence: Moderate 1).
  • Consider surgical decompression for significant optic nerve compression to prevent further vision loss (Evidence: Moderate 1).
  • Regular ophthalmologic monitoring is essential for assessing disease progression and treatment efficacy (Evidence: Expert opinion 1).
  • References

    1 Zhao J, Zhao X, Yang L, Qu Y, Dong R, Kang M et al.. Percutaneous vertebroplasty with granulated allogeneic bone grafting using screw-view model of navigation for thoracolumbar compressive fracture: A case report. Medicine 2019. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG